Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-23 Sale |
2024-12-26 9:00 pm |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
886,237 | $12.01 | $10,641,739 | 66,074,572 (Direct) |
View |
| 2024-12-18 Sale |
2024-12-20 9:00 pm |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
412,584 | $12.05 | $4,971,637 | 34,947,147 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-23 Exercise |
2024-12-26 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
886,237 | $0 | 66,074,572 (Direct) |
View |
| 2024-12-23 Exercise |
2024-12-26 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
886,237 | $3.85 | 66,074,572 (Direct) |
View |
| 2024-12-18 Exercise |
2024-12-20 9:00 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
412,584 | $0 | 34,947,147 (Direct) |
View |
| 2024-12-18 Exercise |
2024-12-20 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
412,584 | $3.85 | 34,947,147 (Direct) |
View |
| 2024-12-03 Other |
2024-12-05 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
3,651,985 | $12.21 | 22,488,532 (Direct) |
View |
| 2024-07-26 Option Award |
2024-07-30 9:02 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
18,836,547 | $0 | 24,146,230 (Direct) |
View |
| 2024-03-30 Exercise |
2024-04-02 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
729,081 | $0 | 5,309,683 (Direct) |
View |
| 2024-03-30 Tax Withholding |
2024-04-02 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
366,211 | $10.54 | 5,309,683 (Direct) |
View |
| 2024-03-30 Exercise |
2024-04-02 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
1,856,163 | $6.4 | 5,309,683 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
71,365 | $0 | 8,109,865 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
159,100 | $6.4 | 8,109,865 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
28,411 | $11.5 | 8,109,865 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
27,790 | $0 | 8,226,011 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
53,033 | $6.4 | 8,226,011 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
28,411 | $11.5 | 8,226,011 (Direct) |
View |
| 2023-08-27 Exercise |
2023-08-29 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
22,565 | $0 | 6,915,954 (Direct) |
View |
| 2023-08-27 Exercise |
2023-08-29 9:31 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
53,033 | $6.4 | 6,915,954 (Direct) |
View |
| 2023-07-27 Exercise |
2023-07-31 9:35 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
43,212 | $0 | 6,946,422 (Direct) |
View |
| 2023-07-27 Exercise |
2023-07-31 9:35 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
106,067 | $6.4 | 6,946,422 (Direct) |
View |
| 2023-05-27 Exercise |
2023-05-31 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh See Remarks |
99,458 | $0 | 7,009,277 (Direct) |
View |
| 2023-05-27 Exercise |
2023-05-31 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh See Remarks |
318,199 | $6.4 | 7,009,277 (Direct) |
View |
| 2022-04-20 Option Award |
2022-04-22 7:31 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh See Remarks |
16,523,184 | $0 | 16,523,184 (Direct) |
View |
Ownership |
2021-10-01 5:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres &Chief Investment Officer |
0 | $0 | 18,128,339 (Direct) |
View |